Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel (Q46917099)

From Wikidata
Revision as of 17:25, 20 October 2018 by Edoderoobot (talk | contribs) (‎Updated Item: nl-description, python code, logfile on https://goo .gl/BezTim)
Jump to navigation Jump to search
scientific article published on 9 December 2014
Language Label Description Also known as
English
Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel
scientific article published on 9 December 2014

    Statements

    title
    Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    25557266
    retrieved
    26 December 2017
    reference URL
    http://europepmc.org/abstract/MED/25557266
    author name string

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q46917099&oldid=768665674"